Benzocaine
(BLFLLBZGZJTVJG-UHFFFAOYSA-N)
Structure
- SMILES
- CCOC(=O)c1ccc(cc1)N
- Type(s)
- Approved; Investigational
- ATC code(s)
- C05AD03; D04AB04; N01BA05; R02AD01
- Molecular Formula:
- C9H11NO2
- Molecular Weight:
- 165.189
- Log P:
- 2.0267
- Hydrogen Bond Acceptor:
- 3
- Hydrogen Bond Donor:
- 1
- TPSA:
- 52.32
- CAS Number(s):
- 94-09-7; 9011-18-1; 34584
Synonym(s)
1.
Benzocaine
2.
Ethyl Aminobenzoate
3.
4-Aminobenzoic Acid Ethyl Ester
4.
Americaine
5.
Anaesthesin
6.
Anesthesin
7.
Bensokain
8.
Benzocaine Acetate
9.
Benzocaine Formate
10.
Benzocaine Hydrobromide
11.
Benzocaine Hydrochloride
12.
Benzocaine Methanesulfonate
13.
Ethoform
14.
Acetate, Benzocaine
15.
Formate, Benzocaine
16.
Hydrobromide, Benzocaine
17.
Hydrochloride, Benzocaine
18.
Methanesulfonate, Benzocaine
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Cyanosis | FAERS: 14 Canada Vigilance: 2 | 9779022 17612444 | CTD SIDER Canada Vigilance US FAERS |
| 2 | Hypersensitivity | FAERS: 4 | SIDER US FAERS | |
| 3 | Hypoxia | FAERS: 4 | US FAERS | |
| 4 | Medication Error | FAERS: 3 | US FAERS | |
| 5 | Mental status changes | FAERS: 3 | US FAERS | |
| 6 | Pallor | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Respiratory Failure | FAERS: 3 | US FAERS | |
| 8 | Tachycardia | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Toxicity to various agents | FAERS: 3 | US FAERS | |
| 10 | Dizziness | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Drug ineffective | FAERS: 2 | US FAERS | |
| 12 | Expired drug administered | FAERS: 2 | US FAERS | |
| 13 | Headache | FAERS: 2 | US FAERS | |
| 14 | Lethargy | FAERS: 2 | US FAERS | |
| 15 | Nausea | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 16 | Overdose | FAERS: 2 | US FAERS | |
| 17 | PO2 decreased | FAERS: 2 | US FAERS | |
| 18 | Post procedural complication | FAERS: 2 | US FAERS | |
| 19 | Pruritus | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 20 | Respiratory distress | FAERS: 2 | SIDER US FAERS | |
| 21 | Somnolence | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 22 | Abdominal Pain | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 23 | Accidental exposure to product by child | FAERS: 1 | US FAERS | |
| 24 | Anisocytosis | FAERS: 1 | US FAERS | |
| 25 | Aphasia | FAERS: 1 | US FAERS | |
| 26 | Application site erythema | FAERS: 1 | US FAERS | |
| 27 | Application site pain | FAERS: 1 | US FAERS | |
| 28 | Blood pH increased | FAERS: 1 | US FAERS | |
| 29 | Bradycardia | FAERS: 1 | US FAERS | |
| 30 | Burning sensation | FAERS: 1 | US FAERS | |
| 31 | Chest discomfort | FAERS: 1 | US FAERS | |
| 32 | Circumstance or information capable of leading to medication error | FAERS: 1 | US FAERS | |
| 33 | Depressed Level of Consciousness | FAERS: 1 | US FAERS | |
| 34 | Disorientation | FAERS: 1 | US FAERS | |
| 35 | Drooling | FAERS: 1 | US FAERS | |
| 36 | Erythema | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 37 | Exposure via ingestion | FAERS: 1 | US FAERS | |
| 38 | Fatigue | FAERS: 1 | US FAERS | |
| 39 | General physical health deterioration | FAERS: 1 | US FAERS | |
| 40 | Hemiparesis | FAERS: 1 | US FAERS | |
| 41 | Hypotension | FAERS: 1 | US FAERS | |
| 42 | Malaise | FAERS: 1 | US FAERS | |
| 43 | Musculoskeletal stiffness | FAERS: 1 | US FAERS | |
| 44 | Myocardial Infarction | FAERS: 1 | US FAERS | |
| 45 | Oropharyngeal blistering | FAERS: 1 | US FAERS | |
| 46 | Palpitations | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 47 | Pharmaceutical product complaint | FAERS: 1 | US FAERS | |
| 48 | Prescription drug used without a prescription | FAERS: 1 | US FAERS | |
| 49 | Product container issue | FAERS: 1 | US FAERS | |
| 50 | Product lot number issue | FAERS: 1 | US FAERS | |
| 51 | Product quality issue | FAERS: 1 | US FAERS | |
| 52 | Red blood cell poikilocytes present | FAERS: 1 | US FAERS | |
| 53 | Respiratory arrest | FAERS: 1 | US FAERS | |
| 54 | Sinus Tachycardia | FAERS: 1 | US FAERS | |
| 55 | Suicide attempt | FAERS: 1 | US FAERS | |
| 56 | Swelling | FAERS: 1 | SIDER US FAERS | |
| 57 | Unevaluable event | FAERS: 1 | US FAERS | |
| 58 | Urticaria | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 59 | Vomiting | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 60 | Vulvovaginal burning sensation | FAERS: 1 | US FAERS | |
| 61 | Vulvovaginal erythema | FAERS: 1 | US FAERS | |
| 62 | Vulvovaginal pain | FAERS: 1 | US FAERS | |
| 63 | Vulvovaginal swelling | FAERS: 1 | US FAERS | |
| 64 | Anemia, Hemolytic | 2933656 | CTD | |
| 65 | Angioedema | 12899608 | CTD | |
| 66 | Application site burn | Canada Vigilance: 1 | Canada Vigilance | |
| 67 | Application site rash | Canada Vigilance: 1 | Canada Vigilance | |
| 68 | Application site vesicles | Canada Vigilance: 1 | Canada Vigilance | |
| 69 | Chest Pain | 17612444 | CTD | |
| 70 | Dermatitis, Allergic Contact | 11298694 18383004 | CTD | |
| 71 | Dermatitis | SIDER | ||
| 72 | Feeling Cold | Canada Vigilance: 2 | Canada Vigilance | |
| 73 | Hypesthesia | 20565405 | CTD | |
| 74 | Inflammation | Canada Vigilance: 1 | Canada Vigilance | |
| 75 | Methemoglobinemia | CTD | ||
| 76 | Pain | Canada Vigilance: 1 | 2490060 | CTD Canada Vigilance |
| 77 | Pharyngitis | 20533760 | CTD | |
| 78 | Pigmentation Disorders | 20565405 | CTD | |
| 79 | Redness | SIDER | ||
| 80 | Unresponsive to stimuli | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.